Skip to main content icon/video/no-internet

The number of people over the age of 65 is increasing, a trend that will continue in the foreseeable future. A considerable volume of evidence exists to support the contention that immune system function deteriorates as human beings age. The decline in immune function, frequently called immunosenescence, is often attributed to thymic involution and the associated impairments in T-cell function. More recent evidence points to the decline in antigen naive cells and the accumulation of regulatory T cells (Treg or suppressor T cells), which appears to coincide with aging. Innate immunity also appears to decline with age, with impaired dendritic cell and macrophage function. These cells are responsible for presenting antigen to the adaptive arm of the immune system. B-cell function, and the associated antibody production is frequently shown to be normal in older individuals, but overall, B-cell function is impaired by the decline in antibody-producing plasma cells, which is functionally evident in the impaired response to vaccines in the elderly.

Aging is linked to an increased number of infections, autoimmune diseases, and cancers—many likely attributable to a decline in host defense. More recently, aging has been linked to a hyperinflammatory state, which has been implicated in the risk of cardiovascular disease, diabetes, and other chronic diseases. In 2000, Claudio Franceschi coined the term inflamm-aging to describe the coincident increase in morbidities and inflammation observed in older persons. Franceschi and coworkers suggested that inflammaging is caused by lifelong exposure to acute and chronic infections and the resulting cumulative antigenic burden. Simply put, a lifetime of fighting infection takes its toll on the immune system.

In this entry, various aspects of declines in the immune system with aging and potential comorbid associations with inflammation are described. Recent research on the anti-inflammatory actions of regular exercise are contrasted with Franceschi's inflammaging model to allow for the possibility that aging per se is not the cause of all “age-related” phenomena.

Aging and T Cells

Our immune system, intended to shield us from diseases and pathogens, appears to become undermined with increasing age. Immunosenescence is the term used to describe these age-related declines in immune function. A classic explanation for immunosenescence is the involution or shrinking of the thymus gland—responsible for maturation and “education” of the T cells—which has been documented to begin as early as age 13, with greatly reduced (<20%) functional thymic volume remaining by age 60.

T-cell number, T-cell responsiveness, and T-cell growth factor (interleukin 2) are all documented to be lower in older adults. There is also a significant decline in antigen naive T cells, with a concomitant increase in antigen-experienced memory cells—a reduced naive to memory cell ratio. The basic problem is that the immune space is clogged with cells that are unable or less able to respond to new antigen. The naive cells that remain appear to be functionally deficient, respond less effectively to antigen in culture, and have a blunted response to vaccination. Memory cells of older people lack the costimulatory molecules required for cross-talk between T cells and other immune cells, such as the antigen-presenting dendritic cells. High numbers of long-lived memory cells can also lead to an impaired antibody response to vaccine.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading